Bis zu 90% sparen! Kostenloser Depotgebühren-Check
030-275 77 6400
DAX-0,17 % EUR/USD+0,42 % Gold-0,13 % Öl (Brent)-1,19 %

Abiomed to Highlight Importance of Optimal PCI Treatment to Improve Outcomes for High-Risk Patients at TCT 2019

Nachrichtenquelle: Business Wire (engl.)
17.09.2019, 14:35  |  233   |   |   

Abiomed (NASDAQ:ABMD) will highlight the benefits of complete revascularization with Protected PCI and the value of Impella protocol-based treatment for survival and native heart recovery in cardiogenic shock patients at the 31st Transcatheter Cardiovascular Therapeutics (TCT) conference in San Francisco from September 25-29. During the conference, Abiomed will also offer hands-on training to help physicians improve access and closure skills and patient management expertise to achieve improved outcomes.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190917005637/en/

Abiomed will showcase technological innovations at TCT 2019, including Impella CP with SmartAssist, which is designed to improve outcomes by using real-time intelligence to optimize positioning, managing and weaning of the Impella device for better patient care. (Graphic: Business Wire)

Abiomed will showcase technological innovations at TCT 2019, including Impella CP with SmartAssist, which is designed to improve outcomes by using real-time intelligence to optimize positioning, managing and weaning of the Impella device for better patient care. (Graphic: Business Wire)

Optimal Outcomes in Complex Patients Are Driven by Enabling Complete Revascularization and Reducing Risk of Acute Kidney Injury

During two breakfast symposia hosted by Abiomed, interventionalists and fellows will present cases and best practices using Impella devices to improve outcomes.

A symposium on Thursday, September 26, will feature best practices for using percutaneous mechanical circulatory support to enable complete revascularization in complex and sick patients.

The schedule for this symposium is below:

  • Treating the Complex Patients: Impella Enabled Complete Revascularization
    Thursday, September 26
    6:30-7:45 a.m. PDT
    Moscone South, Level 2, Room 209-210
    Chair: William O’Neill, MD
  • Protected PCI: A Contemporary Look at Clinical Data from cVAD
    Jeff Popma, MD
  • The Value of Complete Revascularization in a Single Setting
    Raj Patel, MD
  • Driving Quality in PCI: The Benefits of Complete Revascularization for Improvements in Ejection Fraction and Patient Quality of Life
    Ehtisham Mahmud, MD

A second symposium on Friday, September 27, will highlight the most interesting and complex cases submitted by fellows around the globe. Attendees will learn techniques used for the procedures and how to use hemodynamic support to achieve optimal outcomes.

The schedule for this symposium is below:

Management of Complex PCI Patients: Award Winning Case Presentations

Friday, September 27
6:30-7:45 a.m. PDT
Moscone South, Level 2, Room 201-202
Co-Chairs: David Wohns, MD and George Dangas, MD
Panelists: Ayaz Rahman, MD; Justin Levisay, MD; Amir Kaki, MD

  • Successful Resuscitation of Acute Cardiogenic Shock Presenting as Ventricular Fibrillation via Bipella Approach
Diesen Artikel teilen
Seite 1 von 4
Wertpapier

Mehr zum Thema
Klicken Sie auf eines der Themen und seien Sie stets dazu informiert. Mehr Informationen hier.
EuroUSANASDAQInterventionCAI


0 Kommentare

Schreibe Deinen Kommentar

Bitte melden Sie sich an, um zu kommentieren. Anmelden | Registrieren

 

Disclaimer

Meistgelesene Nachrichten des Autors

Titel
Titel
Titel
Titel

Diskussionen zu den Werten

ZeitTitel
26.09.19